Crowdfunding for Life Science Companies: A Practical Path to Commercialization Capital

Raising capital for life science companies has never been more challenging — or more creative. Traditional venture funding is slower, more selective, and increasingly focused on short exit timelines. At the same time, regulatory changes have opened powerful new opportunities through equity crowdfunding.

Drawing on 30+ years of experience and real-world case studies, this session goes beyond theory to show what actually works. You’ll learn when crowdfunding makes sense, how to structure offerings, how much marketing truly matters, and how to avoid common regulatory and investor pitfalls.

What you’ll learn:

• Why crowdfunding is gaining traction in today’s life science funding environment
• How Reg CF and Reg A+ work — and what you can realistically raise
• What makes an “easily understood story” investors respond to
• How to define and reach your Ideal Investor Profile (IIP)
• The real costs, timelines, and marketing effort required to succeed
• How crowdfunding fits into a long-term (10+ year) funding strategy
• Critical watch-outs around FDA language, governance, and cap tables

Whether you’re pre-revenue, grant-funded, or preparing for commercialization, this webinar provides a clear, no-nonsense look at how crowdfunding can complement — not replace — other funding sources while validating market demand and accelerating momentum.

About Michele -

Michele Zoromski is a veteran commercialization strategist whose firm, m.zoro Consulting, bridges the gap between technical brilliance and market success for life science innovators. With a track record of guiding over 250 ventures, she specializes in securing diverse funding sources and authoring high-stakes due diligence for multimillion-dollar deals. Beyond consulting, she mentors top-tier startups to MN Cup victories and accelerates industry growth through her membership in the elite Bullpen Ventures network.